Frontlight ResearchEarly access
Trial site
Hopital Claude Huriez - Chu Lille
- 7running trials
- 1closed trial
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Melanoma3 trials
- Gastric and oesophageal cancer2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Chronic lymphocytic leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Endometrial cancer1 trial
- Follicular lymphoma1 trial
- Head and neck cancer1 trial
- Lung cancer1 trial
- Lupus (SLE)1 trial
- Mantle cell lymphoma1 trial
- and 3 more
- Phase
- Phase 35 trials
- Phase 1/21 trial
- Phase 21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting4 trials
- Recruiting3 trials
- Completed1 trial
- Lead sponsor
- Hoffmann-La Roche3 trials
- Daiichi Sankyo2 trials
- BeOne Medicines1 trial
- Biogen1 trial
- Pierre Fabre Medicament1 trial
Running trials
Recruiting
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Active, not recruiting
Active, not recruiting
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gastric and oesophageal cancer2 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Endometrial cancer1 recruiting
- Follicular lymphoma1 recruiting
- Head and neck cancer1 recruiting
- Lung cancer1 recruiting
- Mantle cell lymphoma1 recruiting
- Melanoma1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026